Reuters logo
U.S. FDA approves Merck insomnia drug
August 13, 2014 / 7:46 PM / 3 years ago

U.S. FDA approves Merck insomnia drug

WASHINGTON, Aug 13 (Reuters) - The U.S. Food and Drug Administration said on Wednesday it has approved a new insomnia drug made by Merck & Co..

The drug, to be called Belsomra, is the first in a new class of sedatives that block chemicals in the brain called orexins that help keep people awake.

Belsomra, known generically as suvorexant, has the potential to cause next-day sleepiness and impaired driving.

The FDA approved the drug in four different strengths, with 20 milligrams being the maximum. (Reporting by Toni Clarke; Editing by Sandra Maler)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below